Rapport Therapeutics (RAPP) Prepaid Assets (2023 - 2026)
Rapport Therapeutics (RAPP) posted quarterly Prepaid Assets of $7.8 million for Q1 2026, up 41.4% year-over-year from $5.5 million in Q1 2025, and down 2.11% quarter-over-quarter from $7.9 million in Q4 2025.
Rapport Therapeutics (RAPP) Prepaid Assets (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has reported Prepaid Assets for 4 consecutive years, with $7.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 41.4% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (up 41.4% YoY), while the FY2025 annual figure was $7.9 million, up 79.24% from the prior year.
- Prepaid Assets fell to $7.8 million in Q1 2026 per RAPP's latest filing, from $7.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.7 million in Q2 2025 and bottomed at $1.5 million in Q4 2023.
- Historically, Prepaid Assets has averaged $6.0 million across 4 years, with a median of $5.5 million in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 194.47% — and 2026, when it jumped 41.4%.
- Rapport Therapeutics' Prepaid Assets stood at $1.5 million in 2023, then soared by 194.47% to $4.4 million in 2024, then soared by 79.24% to $7.9 million in 2025, then retreated by 2.11% to $7.8 million in 2026.
- Business Quant data shows RAPP's Prepaid Assets at $7.8 million in Q1 2026, $7.9 million in Q4 2025, and $7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rapport Therapeutics | 2.27 Bn | 2.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.38 Mn |
| Mar 31, 2026 | 7.75 Mn |
| Dec 31, 2025 | 7.92 Mn |
| Sep 30, 2025 | 7.53 Mn |
| Jun 30, 2025 | 9.69 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 4.42 Mn |
| Dec 31, 2023 | 1.50 Mn |